Met Life Investment Management, LLC Chimerix Inc Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 10, 2024	BUY	$1.67 - $2.35 $3,179 - $4,474	1,904 Added 4.45%	44,657 $83,000
Q4 2022 Jun 14, 2023	BUY	$1.67 - $2.35 $74,577 - $104,943	44,657 New	44,657 $83,000
Q4 2022 Mar 22, 2023	BUY	$1.67 - $2.35 $3,179 - $4,474	1,904 Added 4.45%	44,657 $83,000
Q4 2022 Feb 15, 2023	BUY	$1.67 - $2.35 $74,577 - $104,943	44,657 New	44,657 $83,000
Q2 2022 Aug 11, 2022	SELL	$1.34 - $5.34 $57,289 - $228,301	-42,753 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$4.58 - $6.8 $195,808 - $290,720	42,753 New	42,753 $195,000
Q1 2022 Jun 20, 2023	BUY	$4.58 - $6.8 $195,808 - $290,720	42,753 New	42,753 $195,000
Q1 2022 Mar 22, 2023	BUY	$4.58 - $6.8 $70,412 - $104,543	15,374 Added 56.15%	42,753 $195,000
Q1 2022 May 12, 2022	BUY	$4.58 - $6.8 $70,412 - $104,543	15,374 Added 56.15%	42,753 $196,000
Q4 2021 May 17, 2024	BUY	$5.23 - $7.18 $63,879 - $87,696	12,214 Added 80.54%	27,379 $176,000
Q4 2021 Jun 21, 2023	BUY	$5.23 - $7.18 $143,192 - $196,581	27,379 New	27,379 $176,000
Q4 2021 Mar 22, 2023	BUY	$5.23 - $7.18 $63,879 - $87,696	12,214 Added 80.54%	27,379 $176,000
Q4 2021 Feb 15, 2022	BUY	$5.23 - $7.18 $63,879 - $87,696	12,214 Added 80.54%	27,379 $176,000
Q3 2021 May 17, 2024	SELL	$5.94 - $8.75 $79,441 - $117,022	-13,374 Reduced 46.86%	15,165 $93,000
Q3 2021 Jun 21, 2023	BUY	$5.94 - $8.75 $90,080 - $132,693	15,165 New	15,165 $93,000
Q3 2021 Mar 22, 2023	SELL	$5.94 - $8.75 $79,441 - $117,022	-13,374 Reduced 46.86%	15,165 $93,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $79,441 - $117,022	-13,374 Reduced 46.86%	15,165 $94,000
Q2 2021 May 17, 2024	BUY	$7.54 - $9.79 $150,634 - $195,584	19,978 Added 233.36%	28,539 $228,000
Q2 2021 Jun 21, 2023	BUY	$7.54 - $9.79 $215,184 - $279,396	28,539 New	28,539 $228,000
Q2 2021 Mar 22, 2023	BUY	$7.54 - $9.79 $150,634 - $195,584	19,978 Added 233.36%	28,539 $228,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $150,634 - $195,584	19,978 Added 233.36%	28,539 $228,000
Q1 2021 May 17, 2024	BUY	$4.76 - $11.25 $40,750 - $96,311	8,561 New	8,561 $82,000
Q1 2021 Jun 26, 2023	BUY	$4.76 - $11.25 $40,750 - $96,311	8,561 New	8,561 $82.5 Million
Q1 2021 Mar 22, 2023	SELL	$4.76 - $11.25 $171,816 - $406,080	-36,096 Reduced 80.83%	8,561 $82,000
Q1 2021 May 14, 2021	BUY	$4.76 - $11.25 $40,750 - $96,311	8,561 New	8,561 $83,000
Q2 2018 Aug 15, 2018	SELL	$4.43 - $5.14 $107,835 - $125,117	-24,342 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.65 - $5.9 $113,190 - $143,617	24,342 New	24,342 $127,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account